Diana Morante-Aguilar

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness.

Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness.

Journal: International journal of molecular sciences

Published: November 30, 2022

Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.

Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.

Journal: Neuro-oncology

Published: May 24, 2022

CtIP-dependent nascent RNA expression flanking DNA breaks guides the choice of DNA repair pathway.

CtIP-dependent nascent RNA expression flanking DNA breaks guides the choice of DNA repair pathway.

Journal: Nature communications

Published: January 11, 2022

Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma.

Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma.

Journal: Biomedicines

Published: January 10, 2022

A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma.

A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma.

Journal: Journal of medicinal chemistry

Published: January 27, 2021

Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95].

Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95].

Journal: EBioMedicine

Published: February 29, 2020

Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".

Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".

Journal: EBioMedicine

Published: February 12, 2020

SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells.

SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells.

Journal: Nature communications

Published: October 20, 2019

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.

Journal: EBioMedicine

Published: April 29, 2019

CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease.

CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease.

Journal: Scientific reports

Published: May 22, 2017

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.

Journal: Oncotarget

Published: November 04, 2016

Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.

Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.

Journal: Journal of neuroinflammation

Published: May 09, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026